← Leaderboards
Wayne Mitzner
Johns Hopkins University
$20,452,046
Attributed
$22,345,876
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$46,719,130 · 15
By mechanism
P01$34,954,790 · 10
R01$10,272,939 · 2
U18$1,049,973 · 1
P30$359,428 · 1
R03$82,000 · 1
Top collaborators
- Alan L Scott4 shared
- Brendan J Canning2 shared
- Marian Kollarik2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Elizabeth Wagner$9,262,640
- Dax Fu$8,121,039
- Brendan J Canning$6,876,349
- Sekhar M Pothireddy$12,196,316
- Marian Kollarik$3,965,824
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungChronicInflammationTissuesResponsePathologyAsthmaMacrophageCellsInflammatoryAcuteProgramsDesignIn VivoCd4 Positive T LymphocytesT-LymphocyteLeadAnimalsHistologyResearch StudyInjuryMeasurementPlayMacrophage Activation
Grant awards (72)
Mechanism of pathogenic macrophage activation in emphysema$597,019
R01 · FY2021 · HL · contact PI
Mechanism of pathogenic macrophage activation in emphysema$597,019
R01 · FY2020 · HL · contact PI
Mechanism of pathogenic macrophage activation in emphysema$597,019
R01 · FY2019 · HL · contact PI
Mechanism of pathogenic macrophage activation in emphysema$596,640
R01 · FY2018 · HL · contact PI
Neuromodulation for Asthma$508,668
U18 · FY2017 · TR
Neuromodulation for Asthma$541,305
U18 · FY2016 · TR
Mechanisms Underlying Chronic Lung Pathology$1,806,333
P01 · FY2015 · HL · contact PI
CD4+t-cells control angiogenesis in chronic lung ischemia$481,957
P01 · FY2015 · HL · contact PI
Role of CD8+T cells and macrophages in chronic emphysema$481,163
P01 · FY2015 · HL · contact PI
Regulation of pulmonary fibrosis by CD4+T cells$417,795
P01 · FY2015 · HL · contact PI
Administrative$166,789
P01 · FY2015 · HL · contact PI
Histology$165,451
P01 · FY2015 · HL · contact PI
Flow Cytometery$93,178
P01 · FY2015 · HL · contact PI
Mechanisms Underlying Chronic Lung Pathology$1,796,135
P01 · FY2014 · HL · contact PI
Role of CD8+T cells and macrophages in chronic emphysema$474,233
P01 · FY2014 · HL · contact PI
CD4+t-cells control angiogenesis in chronic lung ischemia$472,073
P01 · FY2014 · HL · contact PI
Regulation of pulmonary fibrosis by CD4+T cells$411,497
P01 · FY2014 · HL · contact PI
Administrative$179,451
P01 · FY2014 · HL · contact PI
Histology$164,430
P01 · FY2014 · HL · contact PI
Flow Cytometery$94,451
P01 · FY2014 · HL · contact PI
Mechanisms Underlying Chronic Lung Pathology$1,716,648
P01 · FY2013 · HL · contact PI
Role of CD8+T cells and macrophages in chronic emphysema$454,460
P01 · FY2013 · HL · contact PI
CD4+t-cells control angiogenesis in chronic lung ischemia$452,014
P01 · FY2013 · HL · contact PI
Regulation of pulmonary fibrosis by CD4+T cells$396,241
P01 · FY2013 · HL · contact PI
Administrative$161,018
P01 · FY2013 · HL · contact PI
Histology$159,993
P01 · FY2013 · HL · contact PI
Flow Cytometery$92,922
P01 · FY2013 · HL · contact PI
Mechanisms Underlying Chronic Lung Pathology$1,800,824
P01 · FY2012 · HL · contact PI
Role of CD8+T cells and macrophages in chronic emphysema$470,532
P01 · FY2012 · HL · contact PI
CD4+t-cells control angiogenesis in chronic lung ischemia$468,216
P01 · FY2012 · HL · contact PI
Regulation of pulmonary fibrosis by CD4+T cells$412,767
P01 · FY2012 · HL · contact PI
Administrative$182,241
P01 · FY2012 · HL · contact PI
Histology$168,451
P01 · FY2012 · HL · contact PI
Flow Cytometery$98,617
P01 · FY2012 · HL · contact PI
Mechanisms Underlying Chronic Lung Pathology$1,785,880
P01 · FY2011 · HL · contact PI
A NEW APPROACH FOR THE TREATMENT OF ASTHMA$766,073
R01 · FY2011 · HL · contact PI
Role of CD8+T cells and macrophages in chronic emphysema$466,329
P01 · FY2011 · HL · contact PI
Administrative$170,598
P01 · FY2011 · HL · contact PI
A NEW APPROACH FOR THE TREATMENT OF ASTHMA$773,823
R01 · FY2010 · HL · contact PI
Targeting AP-1 proteins in COPD$82,000
R03 · FY2010 · HL · contact PI
Pathophysiologic Consequences of Lung Distension$1,911,640
P01 · FY2009 · HL · contact PI
A NEW APPROACH FOR THE TREATMENT OF ASTHMA$779,347
R01 · FY2009 · HL · contact PI
Responses of Contracted Airways and Parenchyma to Stretch in Vivo$504,949
P01 · FY2009 · HL · contact PI
Pathophysiologic Consequences of Lung Distension$1,827,103
P01 · FY2008 · HL · contact PI
A NEW APPROACH FOR THE TREATMENT OF ASTHMA$760,391
R01 · FY2008 · HL · contact PI
Responses of Contracted Airways and Parenchyma to Stretch in Vivo$483,631
P01 · FY2008 · HL · contact PI
Pathophysiologic Consequences of Lung Distension$1,816,206
P01 · FY2007 · HL · contact PI
A NEW APPROACH FOR THE TREATMENT OF ASTHMA$779,322
R01 · FY2007 · HL · contact PI
Responses of Contracted Airways and Parenchyma to Stretch in Vivo$481,766
P01 · FY2007 · HL · contact PI
CORE--ENVIRONMENTAL LUNG DISEASE$78,560
P30 · FY2007 · ES · contact PI
Pathophysiologic Consequences of Lung Distension$1,819,080
P01 · FY2006 · HL · contact PI
Responses of Contracted Airways and Parenchyma to Stretch in Vivo$452,339
P01 · FY2006 · HL · contact PI
Pathophysiologic Consequences of Lung Distension$1,804,252
P01 · FY2005 · HL
New Approach For The Treatment of Asthma$817,885
R01 · FY2005 · HL
Responses of Contracted Airways and Parenchyma to Stretch in Vivo$437,577
P01 · FY2005 · HL
Administrative Core$159,083
P01 · FY2005 · HL
New Approach For The Treatment of Asthma$804,434
R01 · FY2004 · HL
MECHANISM OF INFLAMMATION INDUCED AIRWAY HYPERREACTIVITY$1,618,907
P01 · FY2003 · HL
New Approach For The Treatment of Asthma$783,436
R01 · FY2003 · HL
MECHANISM OF INFLAMMATION INDUCED AIRWAY HYPERREACTIVITY$1,594,290
P01 · FY2002 · HL
New Approach For The Treatment of Asthma$763,051
R01 · FY2002 · HL
CORE--ENVIRONMENTAL LUNG DISEASE$0
P30 · FY2002 · ES
CORE--ENVIRONMENTAL LUNG DISEASE$0
P30 · FY2002 · ES
INFLAMMATORY ALTERATIONS ON AIRWAY MECHANICS IN VIVO$0
P01 · FY2002 · HL
MECHANISM OF INFLAMMATION INDUCED AIRWAY HYPERREACTIVITY$1,545,223
P01 · FY2001 · HL
New Approach For The Treatment of Asthma$857,480
R01 · FY2001 · HL
CORE--ENVIRONMENTAL LUNG DISEASE$196,218
P30 · FY2001 · ES
CORE--ENVIRONMENTAL LUNG DISEASE$0
P30 · FY2001 · ES
INFLAMMATORY ALTERATIONS ON AIRWAY MECHANICS IN VIVO$0
P01 · FY2001 · HL
MECHANISM OF INFLAMMATION INDUCED AIRWAY HYPERREACTIVITY$1,530,733
P01 · FY2000 · HL
INFLAMMATORY ALTERATIONS ON AIRWAY MECHANICS IN VIVO$305,324
P01 · FY2000 · HL
CORE--ENVIRONMENTAL LUNG DISEASE$84,650
P30 · FY2000 · ES